AQP4 and neuromyelitis optica: In patients with NMO, the numbers of CD19intCD27highCD38highCD180− B cell PBs are selectively elevated in the peripheral blood and further expanded during relapse; these cells are responsible for the generation of AQP4 antibodies in an IL-6-dependent manner (142).